Social media

At #IRT2025, ICON joins industry leaders to discuss how sponsors and sites can align on investigational drug accountability. From internal IRT systems to third-party platforms, we’ll explore the challenges and opportunit...

Conducting a high-quality SLR requires more than just data - it demands strategic thinking, methodological rigor, and deep therapeutic expertise. ICON’s tailored approach delivers actionable insights that support regulat...

Are we measuring what matters in women’s health? Despite growing awareness, most clinical trials still rely on outcome assessments designed for men. This leads to misdiagnosed symptoms, delayed care, and poorer health o...

Did you know that more than 1 billion people worldwide live with mental health conditions such as anxiety and depression? ICON is a proud supporter of World Mental Health Day and over the past 5 years, has conducted 100+...

Join us at #IRT2025 as we explore the evolving landscape of IMP management. ICON’s Mia Carter will join a panel discussing the tension between sponsor mandates and site autonomy, and how collaboration can drive regulator...

Are biomarkers the key to reversing high failure rates in neurodegenerative trials? Biomarkers are no longer just exploratory tools, they’re central to improving trial precision and outcomes. Join Dr. Peter Schueler, MD...

Latest issue out now. If you, like our thousands of subscribers, would like a convenient way to keep on top of the latest regulatory authority updates, sign up to our free newsletter today: https://ow.ly/UlO350X4NqJ C...

Latest issue out now. If you, like our thousands of subscribers, would like a convenient way to keep on top of the latest regulatory authority updates, sign up to our free newsletter today: https://ow.ly/wzQ950X4eSt C...

ICON offers proven expertise in complex oncology trials, supporting sponsors from trial design through execution. Discover our success stories.​ https://ow.ly/ECj550WY1i4

ICON offers proven expertise in complex oncology trials, supporting sponsors from trial design through execution. Discover our success stories.​ https://ow.ly/Rnix50WY1i2

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Zhang, our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disea...

ICON will be participating in ACOP 2025 in Aurora, Colorado, where we will introduce Yi Z., our new Scientific Director of PK in the Pharmacometrics Department. Yi brings extensive expertise in PK/PD modeling, disease ...